Application 204502
- Type
- ANDA
- Sponsor
- AUROBINDO PHARMA LTD
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | IBANDRONATE SODIUM | IBANDRONATE SODIUM | TABLET;ORAL | EQ 150MG BASE | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 65862-237 | Ibandronate Sodium | Ibandronate Sodium | Aurobindo Pharma Limited | ANDA | Current |
| 65862-237 | Ibandronate Sodium | Ibandronate Sodium | Aurobindo Pharma Limited | ANDA | Current |
| 65862-237 | Ibandronate Sodium | Ibandronate Sodium | Aurobindo Pharma Limited | ANDA | Current |